title: 2015 European guideline on the management of Chlamydia trachomatis infections.
abstract: Chlamydia trachomatis infections, which most frequently are asymptomatic, are major public health concerns globally. The 2015 European C. trachomatis guideline provides: up-to-date guidance regarding broader indications for testing and treatment of C. trachomatis infections; a clearer recommendation of using exclusively-validated nucleic acid amplification tests for diagnosis; advice on (repeated) C. trachomatis testing; the recommendation of increased testing to reduce the incidence of pelvic inflammatory disease and prevent exposure to infection; and recommendations to identify, verify and report C. trachomatis variants. Improvement of access to testing, test performance, diagnostics, antimicrobial treatment and follow-up of C. trachomatis patients are crucial to control its spread. For detailed background, evidence base and discussions, see the background review for the present 2015 European guideline on the management of Chlamydia trachomatis infections (Lanjouw E, et al. Int J STD AIDS. 2015).
authors.affiliation: Department of Dermatology, Erasmus Medical Center, Rotterdam, The Netherlands.
authors.forename: E
authors.initials: E
authors.lastname: Lanjouw
authors.affiliation: Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: S
authors.initials: S
authors.lastname: Ouburg
authors.affiliation: Department of Dermatology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands STI Outpatient Clinic, Infectious Disease Cluster, Health Service Amsterdam, Amsterdam, The Netherlands Center for Infection and Immunology Amsterdam (CINIMA), Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands.
authors.forename: H J
authors.initials: HJ
authors.lastname: de Vries
authors.affiliation: Outpatients' Centre for Infectious Venereodermatological Diseases, Vienna, Austria.
authors.forename: A
authors.initials: A
authors.lastname: Stary
authors.affiliation: University Hospital Birmingham Foundation NHS Trust, Birmingham, United Kingdom.
authors.forename: K
authors.initials: K
authors.lastname: Radcliffe
authors.affiliation: WHO Collaborating Center for Gonorrhoea and other Sexually Transmitted Infections, National Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden magnus.unemo@regionorebrolan.se.
authors.forename: M
authors.initials: M
authors.lastname: Unemo
mesh_terms: D002690:Chlamydia Infections / Q000175:diagnosis / Q000628:therapy; D002692:Chlamydia trachomatis / Q000302:isolation & purification*; D019411:Clinical Laboratory Techniques / Q000592:standards*; D019468:Disease Management; D005060:Europe; D005260:Female; D006801:Humans; D021141:Nucleic Acid Amplification Techniques / Q000592:standards*; D000292:Pelvic Inflammatory Disease; D017410:Practice Guidelines as Topic; D011634:Public Health
keywords: Chlamydia trachomatis; Europe; antibiotic; diagnosis; genital; lymphogranuloma venereum; pelvic inflammatory disease; sexually transmitted infection; treatment